CONSEQUENCES OF CYTOTOXIC T-LYMPHOCYTE INTERACTION WITH MAJOR HISTOCOMPATIBILITY COMPLEX CLASS I-EXPRESSING NEURONS IN-VIVO

Neurons have evolved strategies to evade immune surveillance that include an inability to synthesize the heavy chain of the class I major histocompatibility complex (MHC), proteins that are necessary for cytotoxic T lymphocyte (CTL) recognition of target cells. Multiple viruses have taken advantage of the lack of CTL-mediated recognition and killing of neurons by establishing persistent neuronal infections and thereby escaping attack by antiviral CTL. We have expressed a class I MHC molecule (D-b) in neurons of transgenic mice using the neuron-specific enolase (NSE)promoter to determine the pathogenic consequences of CTL recognition of virally infected, MHC-expressing central nervous system (CNS) neurons. The NSE-D-b transgene was expressed in H-2(b) founder mice, and transgene-derived messenger RNA was detected by reverse transcriptase-polymerase chain reaction in transgenic brains from several Lines. Purified primary neurons from transgenic but not from nontransgenic mice adhered to cover-slips coated with a conformation-dependent monoclonal antibody directed against the D-b molecule and presented viral peptide to CTL in an MHC-restricted manner, indicating that the D-b molecule was expressed on transgenic neurons in a functional form. Transgenic mice infected with the neurotropic lymphocytic choriomeningitis virus (LCMV) and given anti-LCMV, MHC-restricted CTL displayed a high morbidity and mortality when compared with controls receiving MHC-mismatched CTL or expressing alternative transgenes. After CTL transfer, transgenic brains showed an increased number of CD8(+) cells compared with nontransgenic controls as well as an increased rate of clearance of infectious virus from the CNS. Additionally, an increase in blood-brain barrier permeability was detected during viral clearance in NSE-D-b transgenic mice and lasted several months after clearance of virus from neurons. In contrast, LCMV-infected, nontransgenic littermates and mice expressing other gene products from the NSE promoter showed no CNS disease, no increased intraparenchymal CTL, and no blood-brain barrier damage after the adoptive transfer of antiviral CTL. Our study indicates that viral infections and CTL-CNS interactions may induce blood-brain barrier disruptions and neurologic disease by a ''hit-and-run'' mechanism, triggering a cascade of pathogenic events that proceeds in the absence of continual viral stimulation.